Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 06 Oct 2026 for Intellia Therapeutics, Inc., €21k.
Filing timeline
BuySaleMichael P. Dube
Insider track record
Disclosed buys
0
Disclosed sells
7
Signal history
Michael P. Dube: trading record in brief
Michael P. Dube discloses dealings in Intellia Therapeutics, Inc. to SEC (Form 4). Between 1 July 2024 and 2 October 2026, the trades on record add up to 10 filings.
On the market, this insider has only sold: 7 sales, €183k in total. Outside the open market, there are 3 share grants. In 2026 alone, the filings show no purchases and 3 sales.
The record was last updated on 6 October 2026 with an open-market sale (€21k) in Intellia Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael P. Dube
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,864 shares@ US$12.43Common StockSEC:0001193125-26-415541:0
2,641 shares@ US$16.780.0026% mcap24.0% of flowCommon StockSEC:0002019493-26-000002:0
17,250 shares0Common StockSEC:0001193125-26-088236:0
2,989 shares@ US$9.2114.5% of flowCommon StockSEC:0001193125-26-006264:0
1,871 shares@ US$17.3817.1% of flowCommon StockSEC:0001193125-25-230420:0
2,503 shares@ US$9.9513.0% of flowCommon StockSEC:0000950170-25-093844:0
14,000 shares0Common StockSEC:0000950170-25-032141:0
1,372 shares@ US$12.1810.0% of flowCommon StockSEC:0000950170-25-003032:0
2,012 shares@ US$19.0121.3% of flowCommon StockSEC:0000950170-24-112980:0
17,801 shares0Common StockSEC:0000950170-24-081258:0
10 of 10 declarations
